• Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Profit News Report
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
No Result
View All Result
Profit News Report
No Result
View All Result
Home Investing

Why Tesla stock is outperforming other tech giants on Tuesday

by
February 11, 2026
in Investing
0
Why Tesla stock is outperforming other tech giants on Tuesday
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Tesla stock extended its recent rebound on Tuesday, rising for a third consecutive session as investors weighed analyst commentary, strategic developments in the company’s energy business, and changes in senior management.

Tesla shares were up about 1.5% at $423.05. The broader market was mixed, with the S&P 500 flat and the Dow Jones Industrial Average up about 0.4%, trading above the 50,000 level.

The latest gain followed advances of 3.5% on Friday and 1.5% on Monday. The rebound offered some relief after recent weakness.

Tesla closed below $397.05 last Thursday, marking its first close under $400 since late November.

In contrast, other tech giants were having a tough session on Tuesday. Shares of Alphabet, Nvidia, AMD and Apple were all in the red.

Teala stock stabilises after post-earnings weakness

Tesla shares have struggled to gain traction since the company reported fourth-quarter earnings on January 28.

While results exceeded Wall Street expectations, the stock has remained under pressure, reflecting investor caution.

Coming into Tuesday’s session, shares were down more than 3% since the earnings release.

Market participants have said that, despite solid financial performance, investors appear to be waiting for clearer progress on artificial intelligence and autonomous driving initiatives before assigning higher valuations to the stock.

Chief Executive Officer Elon Musk has increasingly emphasised Tesla’s focus on AI, robotics and autonomy, but analysts said tangible milestones in those areas remain key to sustaining a longer-term rally.

Morgan Stanley highlights solar opportunity

Adding to Tuesday’s momentum, Morgan Stanley reiterated its Equalweight rating on Tesla and maintained a $415 price target, close to the stock’s recent trading levels.

The bank’s stance followed Tesla’s tentative announcement to add 100 gigawatts of solar manufacturing capacity.

Morgan Stanley said the expansion aligns with Musk’s broader vision of integrating renewable energy, energy storage and data infrastructure.

The firm noted that Tesla’s balance sheet remains relatively strong, with more cash than debt and a current ratio of 2.16, indicating solid short-term liquidity.

Morgan Stanley said vertical integration in solar manufacturing could support Tesla’s plans to develop solar-powered data centres and create synergies with its energy storage business.

At full capacity, the bank preliminarily estimates that Tesla Solar could add $20 billion to $50 billion in equity value, equivalent to roughly $6 to $14 per share, to the company’s energy segment.

The firm currently values Tesla’s energy business at about $140 billion, or $40 per share.

While the potential uplift is not viewed as material to Tesla’s overall valuation on a standalone basis, Morgan Stanley said the strategy could be justified by longer-term growth and value creation.

Leadership changes signal operational pressure

Separately, Tesla is also making a key management change in its automotive operations.

According to a report by Bloomberg, Joe Ward, Tesla’s vice president for Europe, the Middle East and Africa, will take over leadership of the company’s global sales, service and delivery organisation.

Ward’s appointment comes as Tesla faces slowing electric vehicle demand in the United States and steep sales declines in parts of Europe.

The company has also intensified its investments in artificial intelligence, autonomous driving and humanoid robots, reshaping internal priorities.

The move follows the departure of Tesla’s head of sales for North America and continues a series of senior exits in recent years.

Longtime Musk associate Omead Afshar left last year after overseeing sales and manufacturing in North America.

Milan Kovac, who led the Optimus robot engineering program, and David Lau, Tesla’s longtime software chief, also exited in 2025.

The post Why Tesla stock is outperforming other tech giants on Tuesday appeared first on Invezz

Previous Post

Datadog Q4 earnings: sufficient to justify a 230x earnings multiple?

Next Post

Commodity wrap: bullion falls ahead of key data; oil up on supply disruptions fear

Next Post
Commodity wrap: bullion falls ahead of key data; oil up on supply disruptions fear

Commodity wrap: bullion falls ahead of key data; oil up on supply disruptions fear

  • Trending
  • Comments
  • Latest
Trump’s Fed Criticism Sparks Investor Concerns

Trump’s Fed Criticism Sparks Investor Concerns

April 22, 2025
A look back at Biden’s Remarkable 50-year career in politics

A look back at Biden’s Remarkable 50-year career in politics

March 20, 2025
Fed’s Stagflation Warning Impacts Crypto Markets

Fed’s Stagflation Warning Impacts Crypto Markets

April 21, 2025
Spire Healthcare shares surge 20% after confirming talks with buyout firms

Spire Healthcare shares surge 20% after confirming talks with buyout firms

January 27, 2026
FDA refuses to review Moderna’s mRNA flu vaccine application

FDA refuses to review Moderna’s mRNA flu vaccine application

0
Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

0
The dollar index continues to pull back to a new low

The dollar index continues to pull back to a new low

0
BNGO Stock: BioNano Genomics Analysis and Forecast

BNGO Stock: BioNano Genomics Analysis and Forecast

0
FDA refuses to review Moderna’s mRNA flu vaccine application

FDA refuses to review Moderna’s mRNA flu vaccine application

February 11, 2026
US futures steady as retail sales, jobs and CPI data take center stage

US futures steady as retail sales, jobs and CPI data take center stage

February 11, 2026
Coca-Cola stock slumps as Q4 revenue misses estimates

Coca-Cola stock slumps as Q4 revenue misses estimates

February 11, 2026
CVS Health beats expectations as turnaround strategy gains traction

CVS Health beats expectations as turnaround strategy gains traction

February 11, 2026

Recent News

FDA refuses to review Moderna’s mRNA flu vaccine application

FDA refuses to review Moderna’s mRNA flu vaccine application

February 11, 2026
US futures steady as retail sales, jobs and CPI data take center stage

US futures steady as retail sales, jobs and CPI data take center stage

February 11, 2026
Coca-Cola stock slumps as Q4 revenue misses estimates

Coca-Cola stock slumps as Q4 revenue misses estimates

February 11, 2026
CVS Health beats expectations as turnaround strategy gains traction

CVS Health beats expectations as turnaround strategy gains traction

February 11, 2026
  • Privacy Policy
  • Terms & Conditions
  • Privacy Policy
  • Terms & Conditions

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com

No Result
View All Result
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com